Misunderstanding regarding the carboplatin dose comparison in MRC TE19/EORTC 30982. [electronic resource]
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov 2011
- 4211; author reply 4211-2 p. digital
Publication Type: Letter; Comment
1527-7755
10.1200/JCO.2011.36.1840 doi
Antineoplastic Agents--therapeutic use Carboplatin--therapeutic use Humans Male Orchiectomy Seminoma--therapy Testicular Neoplasms--therapy